AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Exagen Inc. Common Stock
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG001TCQVF6
7.27▼ 0.21 (-2.81%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
7.48
Day's Range
7.17 – 7.46
52-Week Range
2.59 – 12.23
Volume
222.8K
Avg Volume
342.6K
Share Statistics
Shares Outstanding
Employees
220
Exchange
XNAS
Listed
2019-09-19
Share count as of July 30, 2026

Exagen Inc. Common Stock (XGN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Exagen Inc. Common Stock (XGN)
What is Exagen Inc. Common Stock's Market Cap?
Exagen Inc. Common Stock's Market Cap is $176.1M, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's Enterprise Value?
Exagen Inc. Common Stock's Enterprise Value is $177.1M, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's Price / Sales?
Exagen Inc. Common Stock's Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's EV / Revenue?
Exagen Inc. Common Stock's EV / Revenue is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's EV / EBITDA?
Exagen Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's Revenue (TTM)?
Exagen Inc. Common Stock's Revenue (TTM) is $71.1M, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's Net Income (TTM)?
Exagen Inc. Common Stock's Net Income (TTM) is -$18.9M, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's EBITDA?
Exagen Inc. Common Stock's EBITDA is -$10.8M, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's Diluted EPS (TTM)?
Exagen Inc. Common Stock's Diluted EPS (TTM) is -0.78, based on as-reported figures from SEC (XBRL) filings.
What is Exagen Inc. Common Stock's EBITDA Margin?
Exagen Inc. Common Stock's EBITDA Margin is -15.2%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · XGNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+15.9%+11.7%+21.8%+37.9%
Cost of revenue
Gross profit
% of revenue61.3%59.0%55.4%58.4%
Operating expenses:
Selling, general and administrative expenses
Research and development expenses
Total operating expenses
% of revenue69.9%78.7%85.3%76.4%
Loss from operations
% of revenue-8.6%-19.7%-29.9%-18.0%
Interest expense
Loss on extinguishment of debt—
Change in fair value of warrant liability
Other income (expense), net——
Loss before income taxes
Income tax expense
Net loss
% of revenue-16.0%-22.9%-28.1%-41.1%
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)